Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
Sanyal, Arun, Charles, Edgar D, Neuschwander-Tetri, Brent A, Loomba, Rohit, Harrison, Stephen A, Abdelmalek, Manal F, Lawitz, Eric J, Halegoua-DeMarzio, Dina, Kundu, Sudeep, Noviello, Stephanie, Luo,Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(18)31785-9
Date:
December, 2018
File:
PDF, 452 KB
english, 2018